A bulky, biopsy-proven adenocarcinoma in long-segment Barrett's. The surface says cancer, but it cannot say how deep. In this 80-minute live case from Ghent, the team drives a pocket under the most suspicious zone and looks for the muscle retracting sign before committing to the full resection. The case covers dye-guided orientation inside the pocket, the retroflexed distal approach, double-line traction, defect review and stricture prophylaxis, with a running discussion of MDT planning and what R0 does and does not buy the patient.
The clearest statement of the case's central problem and plan: the cancer is biopsy-proven, but surface pattern cannot judge depth, so a pocket is used to look for the muscle retracting sign. Starts on a full sentence, ends after MRS is defined as a sensitive sign of deep submucosal invasion, and needs no prior context.
A long-segment Barrett's oesophagus with a focal, bulky lesion between 1 and 4 o'clock. The surface is disordered and the vessels are irregular. There is a raised demarcated edge and fibrin centrally from a previous biopsy. Biopsy shows adenocarcinoma. PET is N0 M0.
You do not need a classification to call this. Compared with the flat, regular lining of non-dysplastic Barrett's, this has mass. Classifications earn their place in the borderline cases.
The question is not whether it is cancer. It is how deep it goes.
"It's definitely a cancer, but what we cannot distinguish from the surface pattern is the depth of the invasion."
The surface pattern cannot tell you the depth of invasion. A bulky, irregular lesion may be deeply invasive, or it may not. In Barrett's, lesions often look worse than they are.
So the plan is the pocket creation method, aimed at one thing: the muscle retracting sign (MRS). This is the fibrotic reaction of infiltrating tumour, seen as tethering of the muscle layer towards the lesion. It is a sensitive sign of deep submucosal invasion.
The pocket also gives you an exit. If you find MRS and the patient has chosen surgery, you can withdraw, clip the pocket entrance and stop. As in POEM, you can go a long way in and still walk away.
"The pocket allows you to sneak underneath the lesion. If you think it's deeply invasive and you do not want to continue with your resection, you can still come out of the pocket and clip the pocket opening and stop it there."
Trainees often say the pocket is the hard part. The tips from this case:
"You cannot expect to do this if you have no margin, because you will annihilate your margin and make it uninterpretable."
The pocket only helps if it passes under the most suspicious, most bulky part of the lesion. Two checks are used:
"If that thing is in the deep submucosa and we are doing ESD and we have MRS, it's going to be R1. And R1 drops all options for the patient."
Deep in the pocket the working plane deteriorates. Distension is poor and the scope is unstable over a fold near the junction. The operator switches to a retroflexed distal incision, well outside the marks, and works back towards the pocket.
A dry cut is used here because the tissue is very vascular. Retroflexion is far more stable. The prerequisite is a normal margin. Without one, this approach destroys the margin and makes it uninterpretable.
"The visualization here is so inferior to what you have in the pocket, which is why we want to go under the invasive part with the pocket, so that you have the best visualization at the most important place."
Under the whole lesion the muscle is clean. There is no tethering and no stretched fibres. The lesion is also not visible through the submucosa, which can be a clue to deep invasion in other cases. The visiting observer, having watched many oesophageal ESDs with MRS, agrees.
That does not mean the lesion is T1a. For Barrett's, the current cut-off for low-risk submucosal invasion is SM1, which is only 500 µm. This could still be SM2. But there are data suggesting that if depth is the only risk factor, outcomes are still acceptable.
What the pocket is really protecting is the R0 resection. If the lesion is in the deep submucosa and there is MRS, ESD in the usual plane will give an R1. An R1 removes options for the patient.
For any lesion predicted optically to be deeply invasive, the plan should be agreed in advance, with the patient and through the MDT.
Shaving a little of the circular muscle, a "muscle patch" on the specimen, is increasingly done without perforation. It gives the pathologist a much better chance of a confident deep-margin call. It also does not prevent a later surgical resection if one is needed.
This patient is comorbid. The MDT had discussed him, and he had asked for every available form of endoscopic therapy. What the team wants to avoid is closing the pocket and bringing the patient back for a second attempt. Commit, or stop and close. Don't leave it in between.
After the circumferential incision, two clip-and-line traction devices are placed, one on each side of the opening. Two lines are more stable than one, which tends to flip as the dissection progresses.
Note how much worse the visualisation is outside the pocket, even with traction. This is why the pocket goes under the invasive part: the best view at the most important place. MRS can still appear late in the dissection, so stay alert.
Spray mode keeps the field dry in vascular Barrett's tissue. The cost is heat. In this team's experience, deep margin positivity has not been a problem, probably because of repeated injection. It remains a risk to keep in mind.
The defect review matters for adverse events, not for R0. By this point the R0 has either happened or it hasn't. The defect runs from 32 to 38 cm and covers about half the circumference. Circular muscle is intact throughout. Any vessel that is bleeding or has been cut is coagulated before withdrawal.
At roughly 50% circumference, stricture prophylaxis is oral budesonide 2 mg twice daily for about six weeks, based on a recent Dutch study. Without easy access to the commercial formulation, the team mixes budesonide with honey or jam so that it coats the oesophagus, taken after meals.
Before final photo-documentation, clear all fluid from the oesophagus.
The Ghent group is preparing its Barrett's MRS data for presentation. In the discussion, the sensitivity of MRS for deep submucosal invasion is quoted as over 80%, comparable to their rectal results. False positives occur mainly after previous treatment or in heavily inflamed circumferential Barrett's. False negatives are mostly SM2 lesions, where the boundary with SM3 is less well defined. One false negative was a circumferential lesion where, on video review, the pocket had not targeted the worst zone. These figures are unpublished and should be read as preliminary.
Endoscopists starting Barrett's ESD, those who want to add the pocket creation method to their oesophageal practice, and anyone who sits in an MDT deciding what to do with a bulky early adenocarcinoma.
Access the full course with expert demonstrations, case studies, and clinical pearls.